Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
Recent Posts
Meet the Executive: Brent Burns, Executive Vice President
Over the last two decades, Brent Burns has worked in the ever-changing technology and health space. As an executive at UPMC Enterprises, he draws upon his prior experiences every day.
Read More →
A look back at HIMSS 2019
With HIMSS ’19 wrapped up, we reflect on our experiences and learnings from our time in sunny Orlando, Fl.
Read More →
Vivify Health debuts BYOD remote monitoring tech, talks FHIR at HIMSS19
Vivify Health, a UPMC Enterprises portfolio company, debuted their newest product offering last week at …
Read More →